Unknown

Dataset Information

0

Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.


ABSTRACT: The dCTPase pyrophosphatase 1 (dCTPase) regulates the intracellular nucleotide pool through hydrolytic degradation of canonical and noncanonical nucleotide triphosphates (dNTPs). dCTPase is highly expressed in multiple carcinomas and is associated with cancer cell stemness. Here we report on the development of the first potent and selective dCTPase inhibitors that enhance the cytotoxic effect of cytidine analogues in leukemia cells. Boronate 30 displays a promising in vitro ADME profile, including plasma and mouse microsomal half-lives, aqueous solubility, cell permeability and CYP inhibition, deeming it a suitable compound for in vivo studies.

SUBMITTER: Llona-Minguez S 

PROVIDER: S-EPMC4753678 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.

Llona-Minguez Sabin S   Höglund Andreas A   Jacques Sylvain A SA   Johansson Lars L   Calderón-Montaño José Manuel JM   Claesson Magnus M   Loseva Olga O   Valerie Nicholas C K NCK   Lundbäck Thomas T   Piedrafita Javier J   Maga Giovanni G   Crespan Emmanuele E   Meijer Laurent L   Morón Estefanía Burgos EB   Baranczewski Pawel P   Hagbjörk Ann-Louise AL   Svensson Richard R   Wiita Elisee E   Almlöf Ingrid I   Visnes Torkild T   Jeppsson Fredrik F   Sigmundsson Kristmundur K   Jensen Annika Jenmalm AJ   Artursson Per P   Jemth Ann-Sofie AS   Stenmark Pål P   Berglund Ulrika Warpman UW   Scobie Martin M   Helleday Thomas T  

Journal of medicinal chemistry 20160127 3


The dCTPase pyrophosphatase 1 (dCTPase) regulates the intracellular nucleotide pool through hydrolytic degradation of canonical and noncanonical nucleotide triphosphates (dNTPs). dCTPase is highly expressed in multiple carcinomas and is associated with cancer cell stemness. Here we report on the development of the first potent and selective dCTPase inhibitors that enhance the cytotoxic effect of cytidine analogues in leukemia cells. Boronate 30 displays a promising in vitro ADME profile, includi  ...[more]

Similar Datasets

| S-EPMC3503517 | biostudies-literature
| S-EPMC2966298 | biostudies-literature
| S-EPMC3150642 | biostudies-literature
| S-EPMC3270411 | biostudies-literature
| S-EPMC4491611 | biostudies-literature
| S-EPMC7025381 | biostudies-literature
| S-EPMC4499826 | biostudies-literature
| S-EPMC2878083 | biostudies-literature
| S-EPMC7667872 | biostudies-literature
| S-EPMC4027767 | biostudies-literature